Search Results 1971-1980 of 20043 for Receptor
D., presented the results of his project aimed to improve immune-stimulating chimeric antigen receptor-T cell therapy (CAR T cell therapy) for acute myeloid ...
... receptor occupancy of short- and long-acting oral methylphenidate. Spencer ... According to recent reports, treatment with the NMDA receptor antagonist amantadine ...
Intolerance to all neuro-hormonal antagonists (i.e., intolerance to angiotensin converting enzyme-inhibitors (ACE-I), angiotensin receptor blockers (ARB) ...
Scottsdale/Phoenix, Ariz. The purpose of this study is tol compare the effect of retreatment with 177Lu-DOTATATE peptide receptor radionuclide therapy ...
Specific topics under investigation include molecular analysis of receptors and signal transduction mechanisms; axon guidance, target recognition and ...
Any previous treatment with teprotumumab or other agent that inhibits the IGF-1 receptor * History of systemic (eg, oral or IV) steroid use with a ...
This randomized phase IIB trial studies how well tamoxifen or afimoxifene works in treating patients with estrogen receptor positive breast cancer. Estrogen ...
Therefore, our overarching goal is to determine the effect of weight loss induced by the new generation of GLP-1 receptor agonists on physical function ...
... receptor type 1 blocker over the past 3 months; No episode of decompensated CHF over the past 6 months. Calculated creatinine clearance of equal or less than ...
Her studies focus on a form of breast cancer classified as estrogen receptor positive (ER+), which is usually treated effectively by drugs that block estrogen ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.